7月17日，ASMPT盘中下跌4.23%，报167.0港元，成交额6046.4万港元，延续前一交易日近6%的跌势。
消息面上，尽管摩根大通于7月16日将ASMPT目标价上调至225港元并维持增持评级，但高盛虽大幅上调目标价至206港元却维持中性评级，明确指出正面因素已大致反映在股价中。机构层面，The Capital Group于7月9日减持81.11万股，涉资约1.55亿港元，持股比例降至9.82%；贝莱德持股比例亦从6.13%降至5.48%，南向资金连续多日净卖出，机构集中减仓形成持续压力。公司将于7月28日召开董事会审议中期业绩，业绩窗口期前的不确定性进一步加剧观望情绪。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.